This article is authored by CA CS Yogesh Bhatia, ex-director, Droom Technology Ltd.
China infrastructure advantage remains central to Asian manufacturing competitiveness, shaping efficiency and resilience.
Examining realistic estimates of the cost of outsourcing puts the magic bullet of Chinese manufacturing into question. Nick Dewhurst of Boothroyd Dewhurst has some eye-opening data on what it may ...
Fed-batch and batch bioprocessing still dominate monoclonal antibody (mAb) production, but that must change if mAbs are to become economically viable therapeutic options. Current production techniques ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results